Prescient Therapeutics Limited (PTX.AX)
AUD 0.04
(0.0%)
AUD 0.04
(0.0%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 | 20.39 Million AUD | -27.45% |
| 2023 | 28.1 Million AUD | 59.54% |
| 2022 | 17.61 Million AUD | -15.97% |
| 2021 | 20.96 Million AUD | 73.68% |
| 2020 | 12.07 Million AUD | -19.56% |
| 2019 | 15 Million AUD | 50.21% |
| 2018 | 9.99 Million AUD | -18.31% |
| 2017 | 12.22 Million AUD | -11.6% |
| 2016 | 13.83 Million AUD | 182.83% |
| 2015 | 4.89 Million AUD | -7.35% |
| 2014 | 5.27 Million AUD | 0.0% |
| 2013 | - AUD | -100.0% |
| 2012 | 61.82 Thousand AUD | -91.19% |
| 2011 | 701.85 Thousand AUD | -55.23% |
| 2010 | 1.56 Million AUD | 32.66% |
| 2009 | 1.18 Million AUD | -32.49% |
| 2008 | 1.75 Million AUD | -46.04% |
| 2007 | 3.24 Million AUD | -12.5% |
| 2006 | 3.7 Million AUD | -11.36% |
| 2005 | 4.18 Million AUD | 0.84% |
| 2004 | 4.14 Million AUD | 153.92% |
| 2003 | 1.63 Million AUD | -14.22% |
| 2002 | 1.9 Million AUD | -55.53% |
| 2001 | 4.28 Million AUD | 209.37% |
| 2000 | 1.38 Million AUD | -50.53% |
| 1999 | 2.79 Million AUD | 126.53% |
| 1998 | 1.23 Million AUD | 663.49% |
| 1997 | 161.76 Thousand AUD | 569.66% |
| 1996 | 24.15 Thousand AUD | -98.93% |
| 1995 | 2.24 Million AUD | -61.89% |
| 1994 | 5.9 Million AUD | 6.34% |
| 1993 | 5.54 Million AUD | -18.95% |
| 1992 | 6.84 Million AUD | -3.36% |
| 1991 | 7.08 Million AUD | -1.35% |
| 1990 | 7.18 Million AUD | 9.43% |
| 1989 | 6.56 Million AUD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q4 | 20.39 Million AUD | 0.0% |
| 2024 Q2 | 24.76 Million AUD | 0.0% |
| 2024 FY | 20.39 Million AUD | -27.45% |
| 2023 FY | 28.1 Million AUD | 59.54% |
| 2023 Q2 | 25.88 Million AUD | 0.0% |
| 2023 Q4 | 28.1 Million AUD | 0.0% |
| 2022 FY | 17.61 Million AUD | -15.97% |
| 2022 Q2 | 19.05 Million AUD | 0.0% |
| 2022 Q4 | 17.61 Million AUD | 0.0% |
| 2021 Q4 | 20.96 Million AUD | 0.0% |
| 2021 FY | 20.96 Million AUD | 73.68% |
| 2021 Q2 | 22.62 Million AUD | 0.0% |
| 2020 FY | 12.07 Million AUD | -19.56% |
| 2020 Q2 | 13.39 Million AUD | 0.0% |
| 2020 Q4 | 12.07 Million AUD | 0.0% |
| 2019 FY | 15 Million AUD | 50.21% |
| 2019 Q4 | 15 Million AUD | 0.0% |
| 2019 Q2 | 8.48 Million AUD | 0.0% |
| 2018 FY | 9.99 Million AUD | -18.31% |
| 2018 Q4 | 9.99 Million AUD | 0.0% |
| 2018 Q2 | 10.94 Million AUD | 0.0% |
| 2017 FY | 12.22 Million AUD | -11.6% |
| 2017 Q4 | 12.22 Million AUD | 0.0% |
| 2017 Q2 | 13.46 Million AUD | 0.0% |
| 2016 FY | 13.83 Million AUD | 182.83% |
| 2016 Q2 | 6.2 Million AUD | 0.0% |
| 2016 Q4 | 13.83 Million AUD | 0.0% |
| 2015 FY | 4.89 Million AUD | -7.35% |
| 2015 Q2 | 5.64 Million AUD | 0.0% |
| 2015 Q4 | 4.89 Million AUD | 0.0% |
| 2014 Q4 | 5.27 Million AUD | 0.0% |
| 2014 FY | 5.27 Million AUD | 0.0% |
| 2014 Q2 | 1.62 Million AUD | 0.0% |
| 2013 Q3 | - AUD | 0.0% |
| 2013 Q1 | - AUD | -100.0% |
| 2013 FY | - AUD | -100.0% |
| 2013 Q4 | - AUD | 0.0% |
| 2013 Q2 | - AUD | 0.0% |
| 2012 FY | 61.82 Thousand AUD | -91.19% |
| 2012 Q4 | 61.82 Thousand AUD | 0.0% |
| 2011 FY | 701.85 Thousand AUD | -55.23% |
| 2011 Q4 | 701.85 Thousand AUD | 0.0% |
| 2010 FY | 1.56 Million AUD | 32.66% |
| 2010 Q4 | 1.56 Million AUD | 0.0% |
| 2009 Q4 | 1.18 Million AUD | 0.0% |
| 2009 FY | 1.18 Million AUD | -32.49% |
| 2008 FY | 1.75 Million AUD | -46.04% |
| 2008 Q4 | 1.75 Million AUD | 0.0% |
| 2007 FY | 3.24 Million AUD | -12.5% |
| 2007 Q4 | 3.24 Million AUD | 0.0% |
| 2006 Q4 | 3.7 Million AUD | 0.0% |
| 2006 FY | 3.7 Million AUD | -11.36% |
| 2005 FY | 4.18 Million AUD | 0.84% |
| 2005 Q4 | 4.18 Million AUD | 0.0% |
| 2004 Q4 | 4.14 Million AUD | 0.0% |
| 2004 FY | 4.14 Million AUD | 153.92% |
| 2003 FY | 1.63 Million AUD | -14.22% |
| 2003 Q4 | 1.63 Million AUD | 0.0% |
| 2002 FY | 1.9 Million AUD | -55.53% |
| 2002 Q4 | 1.9 Million AUD | 0.0% |
| 2001 FY | 4.28 Million AUD | 209.37% |
| 2001 Q4 | 4.28 Million AUD | 0.0% |
| 2000 Q4 | 1.38 Million AUD | 0.0% |
| 2000 FY | 1.38 Million AUD | -50.53% |
| 1999 Q4 | 2.79 Million AUD | 0.0% |
| 1999 FY | 2.79 Million AUD | 126.53% |
| 1998 FY | 1.23 Million AUD | 663.49% |
| 1997 FY | 161.76 Thousand AUD | 569.66% |
| 1997 Q4 | 161.76 Thousand AUD | 0.0% |
| 1996 FY | 24.15 Thousand AUD | -98.93% |
| 1995 FY | 2.24 Million AUD | -61.89% |
| 1994 FY | 5.9 Million AUD | 6.34% |
| 1993 FY | 5.54 Million AUD | -18.95% |
| 1992 FY | 6.84 Million AUD | -3.36% |
| 1991 FY | 7.08 Million AUD | -1.35% |
| 1990 FY | 7.18 Million AUD | 9.43% |
| 1989 FY | 6.56 Million AUD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| AdAlta Limited | 5.57 Million AUD | -265.922% |
| Acrux Limited | 8.96 Million AUD | -127.523% |
| Race Oncology Limited | 20.22 Million AUD | -0.812% |
| Biome Australia Limited | 8.27 Million AUD | -146.386% |
| Botanix Pharmaceuticals Limited | 112.46 Million AUD | 81.867% |
| BTC Health Limited | 5.14 Million AUD | -296.069% |
| Chimeric Therapeutics Limited | 15.27 Million AUD | -33.521% |
| CSL Limited | 56.93 Billion AUD | 99.964% |
| Clarity Pharmaceuticals Ltd | 154.62 Million AUD | 86.812% |
| Clinuvel Pharmaceuticals Limited | 231.12 Million AUD | 91.177% |
| EZZ Life Science Holdings Limited | 25.55 Million AUD | 20.191% |
| Hexima Limited | 2.26 Million AUD | -798.758% |
| Immutep Limited | 147.44 Million AUD | 86.17% |
| Memphasys Limited | 12.43 Million AUD | -64.06% |
| Neuren Pharmaceuticals Limited | 247.97 Million AUD | 91.776% |
| Noxopharm Limited | 6.78 Million AUD | -200.613% |
| Radiopharm Theranostics Limited | 72.03 Million AUD | 71.691% |
| Starpharma Holdings Limited | 36.81 Million AUD | 44.606% |
| Tissue Repair Ltd | 19.38 Million AUD | -5.174% |
| Biotron Limited | 493.47 Thousand AUD | -4032.491% |
| Alterity Therapeutics Limited | 19.22 Million AUD | -6.082% |
| Anatara Lifesciences Ltd | 1.67 Million AUD | -1120.09% |
| Bio-Gene Technology Limited | 3.15 Million AUD | -545.427% |
| Zelira Therapeutics Limited | 5.18 Million AUD | -293.425% |
| Patrys Limited | 4.16 Million AUD | -390.027% |
| Orthocell Limited | 26.61 Million AUD | 23.379% |
| Imugene Limited | 151.39 Million AUD | 86.53% |
| PYC Therapeutics Limited | 91.23 Million AUD | 77.649% |
| Proteomics International Laboratories Limited | 10.87 Million AUD | -87.519% |
| Cynata Therapeutics Limited | 8.38 Million AUD | -143.111% |
| Arovella Therapeutics Limited | 13.28 Million AUD | -53.506% |
| Nanollose Limited | 241.95 Thousand AUD | -8328.505% |
| Invex Therapeutics Ltd | 6.12 Million AUD | -233.214% |
| NeuroScientific Biopharmaceuticals Limited | 5.43 Million AUD | -275.153% |
| Amplia Therapeutics Limited | 14.84 Million AUD | -37.371% |
| Island Pharmaceuticals Limited | 2.56 Million AUD | -695.207% |
| Nyrada Inc. | 5.9 Million AUD | -245.217% |
| Telix Pharmaceuticals Limited | 398.3 Million AUD | 94.88% |
| Dimerix Limited | 32.07 Million AUD | 36.428% |
| PharmAust Limited | 11.12 Million AUD | -83.309% |
| AnteoTech Limited | 9.38 Million AUD | -117.38% |
| Paradigm Biopharmaceuticals Limited | 27.39 Million AUD | 25.548% |
| Recce Pharmaceuticals Ltd | 6.36 Million AUD | -220.158% |
| Avecho Biotechnology Limited | 7.31 Million AUD | -178.617% |
| Actinogen Medical Limited | 21.31 Million AUD | 4.312% |
| Immuron Limited | 15.54 Million AUD | -31.144% |
| Argenica Therapeutics Limited | 16.37 Million AUD | -24.517% |